13F-HR filed by Soleus Capital Management, L.P.
Soleus Capital Management, L.P. filed this 13F-HR for the quarter ended 2020-03-31, filed 2020-05-15, with 48 holding rows worth $85,937,000.
- Accession
- 0001802630-20-000004
- Filer
- CIK 1802630
- Filed
- 2020-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2020
A holdings report, 48 entries on the cover page, a total value of $85,937,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $85,936,000 with VALUE read as thousands by filing date, 13F file number 028-20043. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ESSA PHARMA INC | 29668H708 | COM NEW | 2,080,421 | $8,322,000 | thousands by filing date | |
| GRIFOLS S A | 398438408 | SP ADR REP B NVT | 387,035 | $7,795,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 1,607,153 | $5,529,000 | thousands by filing date | |
| HARPOON THERAPEUTICS INC | 41358P106 | COM | 470,926 | $5,453,000 | thousands by filing date | |
| IRADIMED CORP | 46266A109 | COMMON STOCK | 234,810 | $5,013,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 47,800 | $4,292,000 | thousands by filing date | |
| ZYNEX INC | 98986M103 | COM | 348,564 | $3,859,000 | thousands by filing date | |
| DEXCOM INC COM | 252131107 | Stock | 13,450 | $3,622,000 | thousands by filing date | |
| VERICEL CORP | 92346J108 | COM | 352,332 | $3,231,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 313,900 | $3,067,000 | thousands by filing date | |
| EIGER BIOPHARMACEUTICALS INC | 28249U105 | COM | 405,207 | $2,755,000 | thousands by filing date | |
| ALLERGAN PLC | G0177J108 | SHS | 14,600 | $2,586,000 | thousands by filing date | |
| AEGLEA BIOTHERAPEUTICS INC | 00773J103 | COM | 536,497 | $2,500,000 | thousands by filing date | |
| Misonix Inc | 604871103 | COM | 238,333 | $2,245,000 | thousands by filing date | |
| ZYMEWORKS INC | 98985W102 | COM | 61,528 | $2,182,000 | thousands by filing date | |
| ANTARES PHARMA INC | 036642106 | COM | 864,100 | $2,039,000 | thousands by filing date | |
| AbbVie,Inc. | 00287Y109 | COM | 26,500 | $2,019,000 | thousands by filing date | |
| UnitedHealth Group Inc | 91324P102 | COM | 7,900 | $1,970,000 | thousands by filing date | |
| AXONICS INC | 05465P101 | COM | 63,000 | $1,601,000 | thousands by filing date | |
| ITAMAR MED LTD SPONSORED ADS | 465437101 | ADR | 114,865 | $1,353,000 | thousands by filing date | |
| Rafael Holdings Inc Class B | 75062E106 | COM | 89,131 | $1,142,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 257,141 | $1,077,000 | thousands by filing date | |
| ZAFGEN INC | 98885E103 | COM | 1,348,399 | $1,038,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 3,000 | $949,000 | thousands by filing date | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 63,254 | $914,000 | thousands by filing date | |
| AXOGEN INC | 05463X106 | COM | 75,050 | $781,000 | thousands by filing date | |
| MILLENDO THERAPEUTICS INC | 60040X103 | COM | 147,406 | $778,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 16,300 | $727,000 | thousands by filing date | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 16,400 | $696,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 72,000 | $665,000 | thousands by filing date | |
| CONSTELLATION PHARMACEUTICALS INC. | 210373106 | Common Stock | 17,900 | $563,000 | thousands by filing date | |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 10,600 | $545,000 | thousands by filing date | |
| CYTOSORBENTS CORP | 23283X206 | CMN | 69,600 | $538,000 | thousands by filing date | |
| LIVONGO HEALTH INC | 539183103 | COM | 18,100 | $516,000 | thousands by filing date | |
| SHOCKWAVE MED INC | 82489T104 | COM | 12,185 | $404,000 | thousands by filing date | |
| NOVOCURE LTD | G6674U108 | ORD SHS | 5,597 | $377,000 | thousands by filing date | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 11,000 | $375,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 90,000 | $360,000 | thousands by filing date | |
| STAAR SURGICAL CO COM PAR $0.01 | 852312305 | Stock | 7,798 | $252,000 | thousands by filing date | |
| TCR2 THERAPEUTICS INC | 87808K106 | COM | 30,624 | $237,000 | thousands by filing date | |
| PACIRA BIOSCIENCES INC COM | 695127100 | Stock | 7,000 | $235,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 20,980 | $230,000 | thousands by filing date | |
| CHINOOK THERAPEUTICS INC. | 00739L101 | Common Stock | 81,200 | $222,000 | thousands by filing date | |
| AYTU BIOSCIENCE INC | 054754700 | COM PAR | 139,600 | $209,000 | thousands by filing date | |
| VANDA PHARMACEUTICALS INC | 921659108 | COM | 19,000 | $197,000 | thousands by filing date | |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 11,869 | $176,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 13,228 | $150,000 | thousands by filing date | |
| INSMED INC | 457669AA7 | NOTE 1.750% 1/1 | 180,000 | $150,000 | thousands by filing date | principal |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001802630-20-000004 | this filing | 2020-05-15 | acceptance time not in the bulk data set |